Owner/Developer: Aspect Biosystems
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realize these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand.
|Channel:||Website - Social media - Professional online network|
|Audience:||Scientists - Industry - Researchers|
|User access:||Open access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction|
|Purpose:||Method development - Toxicological and safety evaluation|
|Technology/Tools:||Alternative test methods (in vitro) - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.